HomeROVI • VIE
add
Laboratorios Farmaceuticos ROVI SA
Previous close
€78.95
Day range
€83.30 - €83.30
Year range
€38.38 - €83.30
Market cap
4.83B EUR
Avg Volume
4.00
P/E ratio
26.01
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 234.64M | -3.12% |
Operating expense | 72.33M | -7.44% |
Net income | 51.51M | -34.10% |
Net profit margin | 21.95 | -31.98% |
Earnings per share | — | — |
EBITDA | 72.75M | -30.18% |
Effective tax rate | 22.27% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 25.32M | -79.73% |
Total assets | 799.88M | -8.97% |
Total liabilities | 256.39M | -28.25% |
Total equity | 543.49M | — |
Shares outstanding | 51.82M | — |
Price to book | 7.58 | — |
Return on assets | 20.31% | — |
Return on capital | 26.99% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 51.51M | -34.10% |
Cash from operations | 61.03M | -9.69% |
Cash from investing | -26.28M | 32.27% |
Cash from financing | -65.80M | -4,400.68% |
Net change in cash | -31.06M | -213.73% |
Free cash flow | 23.44M | 99.73% |
About
Founded
1946
Website
Employees
1,925